Folic Acid

Last Updated: September 28 2022

Folic acid, the synthetic form of folate, is an essential B-vitamin most well known for its role in preventing neural tube defects in infants. It also has a role in supporting general health but may be detrimental in high amounts.

Folic Acid is most often used for


Folate is the essential vitamin sometimes referred to as Vitamin B9, but more commonly known by its synthetic supplemental form 'folic acid'. Found in low levels across most food products of plant origin and found in enhanced levels in some nation's wheat grain due to fortification, folic acid is a vitamin that has essential roles in the growth of neonates as well as in supporting a process known as methylation in adults.

Folic acid is primarily known as being the 'pregnancy supplement' where women who are planning to conceive children take 400 μg folic acid daily. This is critical in preventing something known as 'neural tube defects' (NTDs) which are caused by insufficient folate provision to the fetus when their neural tube is being formed and the combination of food fortification and supplementation has greatly prevented.

Beyond that, folate and folic acid are used to support methylation in the body. These two supplements, due to eventually forming a molecule known as 5-methyltetrahydrofolate (5-MTHF or L-methylfolate) are involved in indirectly supporting and creating S-Adenosyl Methionine (SAMe) in the body. Due to this, these supplements tend to show quite a bit of similarity to SAMe supplementation and some parallel to supplements involved in the alternate pathway which support SAMe levels (of which supplements like creatine and trimethylglycine (TMG) are implicated in). These parallels are best demonstrated in their effects on depression where they all seem to be implicated in supporting serotonin-based medication (SSRIs usually) as adjuvant with a trend to benefit women more than men.

Despite these benefits, folic acid is unlike other B-vitamins where it does appear to have a potential side-effect when taken in high doses. While taking a very large dose of folic acid several thousand times the RDA will not cause immediate harm it appears that prolonged exposure to levels up to 250% the RDA may be associated with a relative increase in the rates of cancer, particularly colon cancer among the elderly; well demonstrated by acute increases in the rates of colon cancer when both Canada and the US introduced fortification (the rates, of which, have been declining beforehand and ever since). Among the B-vitamins, folate seems to be the one where a balance should be strived in your everyday life and high sources of supplemental folate should be avoided if not intended for other purposes.

Finally, supplements tend to be in one of three forms; folate, folic acid, and L-methylfolate. Of these supplements folic acid is the most common but is thought to be negative when overconsumed. L-methylfolate seems the most promising as many people seem to have genetic mutations in the enzyme which produces L-methylfolate from folate and folic acid, so supplementing the latter two only causes a partial backlog in these people whereas supplementing L-methylfolate may circumvent this genetically disadvantageous rate-limiting step. Furthermore, L-methylfolate seems to be the most promising agent to support SAMe levels as SAMe, as a supplement, is quite expensive and this pathway tends to take on more of the workload than the one creatine and TMG are implicated in.

What else is Folic Acid known as?
Note that Folic Acid is also known as:
  • Folate
  • Vitamin B9
  • Pteroyl L-glutamic acid
Dosage information

The supplement folic acid there are a few options depending on which form you decide to take:

  • When supplementing folate, use up to 400 DFE (400 mcg folate)

  • When supplementing folic acid, use up to 400 DFE (200 mcg is taken on an empty stomach, 240 mcg if taken with a meal)

  • When supplementing L-methylfolate, use 400 mcg. Many supplements seem to give l-methylfolate in doses of 7.5-15 mg a day, but it's unclear if this is necessary, and by all appearances, a normal dose in line with that of folic acid should fulfill the body's requirements.

Supplementing the low doses of folate or folic acid are more than sufficient, in conjunction with a healthy diet, to support bodily levels of all folate metabolites. L-methylfolate is likely unnecessary for many but for those who suspect or know they have a genetic mutation in the MTHFR enzyme (see MTHFR section) then it may prudent to supplement L-methylfolate instead of the other two forms since they are rendered less effective.

All the above do not appear to rely on any timing strategies (single v. multiple doses; morning v. night) and are simply taken once a day.

Join our supplement information course

Examine Database: Folic Acid
What works and what doesn't?

Unlock the full potential of Examine

Get started

Don't miss out on the latest research

Frequently asked questions

Other FAQs

3.^Florio R, di Salvo ML, Vivoli M, Contestabile RSerine hydroxymethyltransferase: a model enzyme for mechanistic, structural, and evolutionary studiesBiochim Biophys Acta.(2011)
5.^Mato JM, Alvarez L, Ortiz P, Pajares MAS-adenosylmethionine synthesis: molecular mechanisms and clinical implicationsPharmacol THer.(1997)
6.^Turner MA, Yang X, Yin D, Kuczera K, Borchardt RT, Howell PLStructure and function of S-adenosylhomocysteine hydrolaseCell Biochem Biophys.(2000)
9.^Craig GM, Elliot C, Hughes KRMasked vitamin B12 and folate deficiency in the elderlyBr J Nutr.(1985)
13.^Agamanolis DP, Chester EM, Victor M, Kark JA, Hines JD, Harris JWNeuropathology of experimental vitamin B12 deficiency in monkeysNeurology.(1976)
15.^Hunter R, Barnes J, Oakeley HF, Matthews DMToxicity of folic acid given in pharmacological doses to healthy volunteersLancet.(1970)
16.^Gibberd FB, Nicholls A, Dunne JF, Chaput de Saintonge DMToxicity of folic acidLancet.(1970)
18.^Richens AToxicity of folic acidLancet.(1971)
19.^Sheehy TWFolic acid: lack of toxicityLancet.(1973)
20.^Suarez RM, Spies TD, Suarez RM Jr.The use of folic acid in sprueAnn Intern Med.(1947)
21.^Kelly P, McPartlin J, Goggins M, Weir DG, Scott JMUnmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplementsAm J Clin Nutr.(1997)
38.^Vandana Rai,* Upendra Yadav, Pradeep Kumar, Sushil Kumar Yadav, and Om Prakesh MishraMaternal Methylenetetrahydrofolate Reductase C677T Polymorphism and Down Syndrome Risk: A Meta-Analysis from 34 StudiesPLoS One.(2014)
42.^David S Wald, Malcolm Law, and Joan K MorrisHomocysteine and cardiovascular disease: evidence on causality from a meta-analysisBMJ.(2002)
47.^Clifford AJ, Arjomand A, Dueker SR, Schneider PD, Buchholz BA, Vogel JSThe dynamics of folic acid metabolism in an adult given a small tracer dose of 14C-folic acidAdv Exp Med Biol.(1998)
50.^Steinberg SE, Campbell CL, Hillman RSKinetics of the normal folate enterohepatic cycleJ Clin Invest.(1979)
51.^Steinberg SEMechanisms of folate homeostasisAm J Physiol.(1984)
52.^V. Michael Whitehead, Roy Pratt, André Viallet, Bernard A. CooperIntestinal Conversion of Folinic Acid to 5-Methyltetrahydrofolate in ManBr J Haematol.(1972)
53.^Smith ME, Matty AJ, Blair JAThe transport of pteroylglutamic acid across the small intestine of the ratBiochim Biophys Acta.(1970)
60.^Zhao R, Diop-Bove N, Visentin M, Goldman IDMechanisms of membrane transport of folates into cells and across epitheliaAnnu Rev Nutr.(2011)
68.^Ross JF, Wang H, Behm FG, Mathew P, Wu M, Booth R, Ratnam MFolate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemiaCancer.(1999)
80.^Wesson VA, Levitt AJ, Joffe RTChange in folate status with antidepressant treatmentPsychiatry Res.(1994)
81.^Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri TFolate, vitamin B12, and homocysteine in major depressive disorderAm J Psychiatry.(1997)
82.^Gilbody S, Lightfoot T, Sheldon TIs low folate a risk factor for depression? A meta-analysis and exploration of heterogeneityJ Epidemiol Community Health.(2007)
85.^Serot JM, Christmann D, Dubost T, Béne MC, Faure GCCSF-folate levels are decreased in late-onset AD patientsJ Neural Transm (Vienna).(2001)
88.^Wu D, Pardridge WMBlood-brain barrier transport of reduced folic acidPharm Res.(1999)
90.^Baxter MG, Miller AA, Webster RASome studies on the convulsant action of folic acidBr J Pharmacol.(1973)
91.^Kehl SJ, McLennan H, Collingridge GLEffects of folic and kainic acids on synaptic responses of hippocampal neuronesNeuroscience.(1984)
93.^Olney JW, Fuller TA, de Gubareff T, Labruyere JIntrastriatal folic acid mimics the distant but not local brain damaging properties of kainic acidNeurosci Lett.(1981)
96.^Solon O, Riddell TJ, Quimbo SA, Butrick E, Aylward GP, Lou Bacate M, Peabody JWAssociations between cognitive function, blood lead concentration, and nutrition among children in the central Philippines.(2008)
97.^Lee MG, Chun OK, Song WODeterminants of the blood lead level of US women of reproductive ageJ Am Coll Nutr.(2005)
104.^Almeida OP, Flicker L, Lautenschlager NT, Leedman P, Vasikaran S, van Bockxmeer FMContribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later lifeNeurobiol Aging.(2005)
105.^Carney MW, Sheffield BFSerum folic acid and B12 in 272 psychiatric in-patientsPsychol Med.(1978)
107.^Sachdev PS, Parslow RA, Lux O, Salonikas C, Wen W, Naidoo D, Christensen H, Jorm AFRelationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community samplePsychol Med.(2005)
113.^Taylor MJ, Carney S, Geddes J, Goodwin GFolate for depressive disordersCochrane Database Syst Rev.(2003)
114.^Loria-Kohen V, Gómez-Candela C, Palma-Milla S, Amador-Sastre B, Hernanz A, Bermejo LMA pilot study of folic acid supplementation for improving homocysteine levels, cognitive and depressive status in eating disordersNutr Hosp.(2013)
118.^Christensen H, Aiken A, Batterham PJ, Walker J, Mackinnon AJ, Fenech M, Hickie IBNo clear potentiation of antidepressant medication effects by folic acid+vitamin B12 in a large community sampleJ Affect Disord.(2011)
120.^Moens AL, Kass DATetrahydrobiopterin and cardiovascular diseaseArterioscler Thromb Vasc Biol.(2006)
121.^Naseem KMThe role of nitric oxide in cardiovascular diseasesMol Aspects Med.(2005)
125.^Low PS, Kularatne SAFolate-targeted therapeutic and imaging agents for cancerCurr Opin Chem Biol.(2009)
130.^Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MPHomocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicityJ Neurosci.(2000)
133.^Valavanidis A, Vlachogianni T, Fiotakis C8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesisJ Environ Sci Health C Environ Carcinog Ecotoxicol Rev.(2009)
134.^Sutton M, Daly LE, Kirke PNSurvival and disability in a cohort of neural tube defect births in Dublin, IrelandBirth Defects Res A Clin Mol Teratol.(2008)
135.^Hibbard BM, Hibbard ED, Jeffcoate TNFolic acid and reproductionActa Obstet Gynecol Scand.(1965)
145.^Farias N, Ho N, Butler S, Delaney L, Morrison J, Shahrzad S, Coomber BLThe effects of folic acid on global DNA methylation and colonosphere formation in colon cancer cell linesJ Nutr Biochem.(2015)
149.^Choi JH, Yates Z, Veysey M, Heo YR, Lucock MContemporary issues surrounding folic Acid fortification initiativesPrev Nutr Food Sci.(2014)
150.^Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, Speizer FE, Willett WCMultivitamin use, folate, and colon cancer in women in the Nurses' Health StudyAnn Intern Med.(1998)
152.^Hirsch S, Sanchez H, Albala C, de la Maza MP, Barrera G, Leiva L, Bunout DColon cancer in Chile before and after the start of the flour fortification program with folic acidEur J Gastroenterol Hepatol.(2009)
153.^Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, Rosenberg IHCancer Epidemiol Biomarkers Prev.(2007)
158.^Lamberti P, Zoccolella S, Iliceto G, Armenise E, Fraddosio A, de Mari M, Livrea PEffects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patientsMov Disord.(2005)
159.^Heikkinen H, Varhe A, Laine T, Puttonen J, Kela M, Kaakkola S, Reinikainen KEntacapone improves the availability of L-dopa in plasma by decreasing its peripheral metabolism independent of L-dopa/carbidopa doseBr J Clin Pharmacol.(2002)
160.^Naughton CA, Chandler CJ, Duplantier RB, Halsted CHFolate absorption in alcoholic pigs: in vitro hydrolysis and transport at the intestinal brush border membraneAm J Clin Nutr.(1989)
161.^Halsted CH, Robles EA, Mezey EIntestinal malabsorption in folate-deficient alcoholicsGastroenterology.(1973)
163.^Halsted CH, Villanueva JA, Devlin AM, Chandler CJMetabolic interactions of alcohol and folateJ Nutr.(2002)
165.^McMartin KE, Collins TD, Shiao CQ, Vidrine L, Redetzki HMStudy of dose-dependence and urinary folate excretion produced by ethanol in humans and ratsAlcohol Clin Exp Res.(1986)
167.^Tamura T, Halsted CHFolate turnover in chronically alcoholic monkeysJ Lab Clin Med.(1983)
169.^Lu SC, Huang ZZ, Yang H, Mato JM, Avila MA, Tsukamoto HChanges in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liverAm J Physiol Gastrointest Liver Physiol.(2000)
171.^Amilburu A, Idoate I, Ponz F, Larralde JInhibition of intestinal absorption of 5-methyltetrahydrofolate by fluoxetineJ Phys Biochem.(2001)
172.^Butterworth CE Jr, Tamura TFolic acid safety and toxicity: a brief reviewAm J Clin Nutr.(1989)
175.^Almeida OP, Marsh K, Alfonso H, Flicker L, Davis TM, Hankey GJB-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trialAnn Neurol.(2010)